Cargando…

Digital and remote behavioral therapies for treating tic disorders: Recent advances and next steps

The rapid expansion of access to and engagement with digital technology over the past 15 years has transformed the potential for remote delivery of evidence-based digital health interventions (DHIs). Digital and remote behavioral interventions have the potential to address current gaps in the provis...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Kareem, Hollis, Chris, Murphy, Tara, Hall, Charlotte L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334700/
https://www.ncbi.nlm.nih.gov/pubmed/35911244
http://dx.doi.org/10.3389/fpsyt.2022.928487
_version_ 1784759161433620480
author Khan, Kareem
Hollis, Chris
Murphy, Tara
Hall, Charlotte L.
author_facet Khan, Kareem
Hollis, Chris
Murphy, Tara
Hall, Charlotte L.
author_sort Khan, Kareem
collection PubMed
description The rapid expansion of access to and engagement with digital technology over the past 15 years has transformed the potential for remote delivery of evidence-based digital health interventions (DHIs). Digital and remote behavioral interventions have the potential to address current gaps in the provision of evidence-based therapies in healthcare services. As the lack of access to behavioral treatments for people with tic disorders is a pressing issue across the world, there is great potential for DHIs to close this treatment gap. Here, we present a critical synthesis of the recent key advances in the field of digitally delivered, remote therapy for tics, outlining the research evidence for the clinical and cost-effectiveness and acceptability of digital or remotely delivered therapy. We found five trials aimed at reducing tic severity in children and young people and one trial for adults. The evidence supports the clinical utility of DHIs to deliver tic therapies, which shows promise in being clinically efficacious compared to an active control. Furthermore, DHIs in trials show good adherence and engagement and are acceptable to patients. The role of human support (including therapists and parents for young people) is likely to be important to encourage adherence. DHIs, where the main therapeutic content is delivered via web-based chapters, are likely to reduce clinical time, and maintain intervention fidelity, but further research is required to understand cost-effectiveness. Despite utilizing randomized controlled trials, only two trials were sufficiently powered to address efficacy and only one trial explored contextual factors that may influence engagement. Moreover, only one trial followed patients for >12 months, thus further long-term follow-ups are required. Specifically, we note that despite an emerging evidence base, DHIs for tics are yet to be routinely implemented in healthcare provision in any country. Drawing on the existing evidence, we conclude by proposing a stepped care model, in which digital therapy is implemented as a widely accessible first-line treatment using a purely online or therapist-supported approach.
format Online
Article
Text
id pubmed-9334700
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93347002022-07-30 Digital and remote behavioral therapies for treating tic disorders: Recent advances and next steps Khan, Kareem Hollis, Chris Murphy, Tara Hall, Charlotte L. Front Psychiatry Psychiatry The rapid expansion of access to and engagement with digital technology over the past 15 years has transformed the potential for remote delivery of evidence-based digital health interventions (DHIs). Digital and remote behavioral interventions have the potential to address current gaps in the provision of evidence-based therapies in healthcare services. As the lack of access to behavioral treatments for people with tic disorders is a pressing issue across the world, there is great potential for DHIs to close this treatment gap. Here, we present a critical synthesis of the recent key advances in the field of digitally delivered, remote therapy for tics, outlining the research evidence for the clinical and cost-effectiveness and acceptability of digital or remotely delivered therapy. We found five trials aimed at reducing tic severity in children and young people and one trial for adults. The evidence supports the clinical utility of DHIs to deliver tic therapies, which shows promise in being clinically efficacious compared to an active control. Furthermore, DHIs in trials show good adherence and engagement and are acceptable to patients. The role of human support (including therapists and parents for young people) is likely to be important to encourage adherence. DHIs, where the main therapeutic content is delivered via web-based chapters, are likely to reduce clinical time, and maintain intervention fidelity, but further research is required to understand cost-effectiveness. Despite utilizing randomized controlled trials, only two trials were sufficiently powered to address efficacy and only one trial explored contextual factors that may influence engagement. Moreover, only one trial followed patients for >12 months, thus further long-term follow-ups are required. Specifically, we note that despite an emerging evidence base, DHIs for tics are yet to be routinely implemented in healthcare provision in any country. Drawing on the existing evidence, we conclude by proposing a stepped care model, in which digital therapy is implemented as a widely accessible first-line treatment using a purely online or therapist-supported approach. Frontiers Media S.A. 2022-07-15 /pmc/articles/PMC9334700/ /pubmed/35911244 http://dx.doi.org/10.3389/fpsyt.2022.928487 Text en Copyright © 2022 Khan, Hollis, Murphy and Hall. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Khan, Kareem
Hollis, Chris
Murphy, Tara
Hall, Charlotte L.
Digital and remote behavioral therapies for treating tic disorders: Recent advances and next steps
title Digital and remote behavioral therapies for treating tic disorders: Recent advances and next steps
title_full Digital and remote behavioral therapies for treating tic disorders: Recent advances and next steps
title_fullStr Digital and remote behavioral therapies for treating tic disorders: Recent advances and next steps
title_full_unstemmed Digital and remote behavioral therapies for treating tic disorders: Recent advances and next steps
title_short Digital and remote behavioral therapies for treating tic disorders: Recent advances and next steps
title_sort digital and remote behavioral therapies for treating tic disorders: recent advances and next steps
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334700/
https://www.ncbi.nlm.nih.gov/pubmed/35911244
http://dx.doi.org/10.3389/fpsyt.2022.928487
work_keys_str_mv AT khankareem digitalandremotebehavioraltherapiesfortreatingticdisordersrecentadvancesandnextsteps
AT hollischris digitalandremotebehavioraltherapiesfortreatingticdisordersrecentadvancesandnextsteps
AT murphytara digitalandremotebehavioraltherapiesfortreatingticdisordersrecentadvancesandnextsteps
AT hallcharlottel digitalandremotebehavioraltherapiesfortreatingticdisordersrecentadvancesandnextsteps